The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease. - Kumar, Divya P.; Caffrey, Rebecca; Marioneaux, Jonathon; Santhekadur, Prasanna K.; Bhat, Madhavi; Alonso, Cristina; Koduru, Srinivas V.; Philip, Binu; Jain, Mukul R.; Giri, Suresh R.; Bedossa, Pierre; Sanyal, Arun J. (Scientific Reports, 2020)